Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night.
Marjot T., Smith K., Westcott F., White S., Johnson E., Srnic N., Barrett A., Hall E., Gralton K., Dennis K., Miller H., Pofi R., Cobbold JFL., Richmond R., Karpe F., Blazev R., Watt MJ., Parker BL., Hodson L., Ray DW., Tomlinson JW.